I mean they did solve the protein folding problem did they? NOt too far fetch to think it can automate cancer research or problem finding in some way.
The field of AI did very well in protein folding, but it was completely different from LLMs.
> I mean they did solve the protein folding problem did they?
They made huge progress, but I would say that the vast majority of work on this problem was designing the harness for the model. That's a lot of work for each and every domain.
There is already (partial) automation there, for example for finding new drug candidates.
Isn't that so far only static folding?
The protein folding solutions like ESM/Alphafold were not due to this LLM/agentic coding or autoresearch type approaches though. They were designed by bio ML researchers.
It's hard to keep track of the frontier on bio ML, but it seems that we're going slower than what Demis Hassabis said in 2024 with 5 years to full cell molecular simulation. We still aren't able to reliably model a tiny surface of the cell membrane.
And of course there's Derek Lowe's takes on the drug discovery pipeline waiting for the proof in the pudding.
To me the only reasonable bullish position is that there is a very non-linear AGI threshold for accelerating progress that we haven't hit yet.
For me personally, I'm looking at other more tractable fields as a proxy to measure this kind of progress. The best modest evidence is from the agentic coding area, (modest because these kinds of gains may not translate to bio progress). Other soft-ish fields to like legal/law/tax are also interesting to watch, as a small amount of people are now trusting AI for these areas that were considered totally unusable a year ago. Another proxy is being able to generate generally entertaining media.